Related Experiment Video
Updated: Jun 22, 2026

Generation of Fluorescent Protein Fusions in Candida Species
Published on: March 4, 2017
[Neonatal candidiasis: therapeutic options]
F Solorzano Santos1, J Reyna Figueroa, M J Torres Munoz
1Hospital de Pediatria CMN Siglo XXI, IMMS, Mexico, DF.
Insights
Neonatal intensive care unit (NICU) factors increase the risk of opportunistic infections, primarily Candida albicans, causing neonatal candidiasis. New antifungal agents offer expanded treatment options for this serious condition.
Area of Science:
- Neonatal medicine
- Infectious diseases
- Mycology
Context:
- Premature infants in intensive care are susceptible to opportunistic infections due to invasive procedures, antibiotics, and parenteral nutrition.
- Candida species, particularly Candida albicans, are the primary cause of neonatal candidiasis.
- Commonly implicated Candida species include C. albicans, C. parapsilosis, and C. tropicalis.
Purpose:
- To review the risk factors for neonatal candidiasis.
- To identify the main causative agents of neonatal candidiasis.
- To outline the available antifungal treatments for neonatal candidiasis.
Summary:
- Diverse risk factors in neonatal intensive care units (NICUs) predispose preterm infants to opportunistic infections.
- Candida albicans is the predominant pathogen responsible for neonatal candidiasis, with C. parapsilosis and C. tropicalis also frequently involved.
- Recent advancements in antifungal therapies, including amphotericin B formulations, fluconazole, itraconazole, and caspofungin, have broadened treatment options.
Impact:
- Highlights the vulnerability of NICU infants to fungal infections.
- Emphasizes the importance of understanding Candida species in neonatal infections.
- Informs clinical practice regarding the management of neonatal candidiasis with newer antifungal agents.
Abstract:
Diverse factors (such as preterm babies with low body weight staying for long-term periods at intensive care units, subjected to invasive procedures, receiving one or more antibiotic schemes, parenteral nutrition, etc.) are considered to pose a risk for the development of infections by opportunistic agents. Of the latter, Candida albicans is considered the main cause of neonatal candidiasis. The most frequently involved Candida species are C. albicans, C. parapsilosis and C. tropicalis. The advent of new antimycotic agents has increased the therapeutic possibilities for the treatment of candidiasis. Antimycotic agents used for the treatment of neonatal candidiasis include: amphotericin B deoxycolate, lipid-associated compounds of amphotericin B, fluconazole and itraconazol, and caspofungin.
Related Concept Videos
Candidiasis
Cryptococcal Meningitis
Antifungal Agents
Pharmacokinetics in Pediatric Patients: Drug Excretion
Urinary Tract Infection IV: Nursing Management
Fungal Phylum Microsporidia
